A gene signature associated with alpha-linolenic acid metabolism predicts clinical prognosis in hepatocellular carcinoma.

OBJECTIVE: Alpha-linolenic acid (ALA) has been implicated in the initiation and progression of multiple cancer types. Nevertheless, the molecular mechanism by which ALA metabolism influences hepatocellular carcinoma (HCC), as well as its effects on t…

Preview only. Read the full abstract at the source